Cáncer de pulmón

Líneas de investigación

  • Inmunoterapia en cáncer de pulmón
  • Registro de tumores torácicos
  • Cáncer de pulmón e infección COVID-19
  • Oncogeriatría
  • Calidad de vida en paciente oncológico
  • Estadificación del cáncer de pulmón

Miembros del equipo

MIREIA MARTÍNEZ KAREAGA

Oncología

NURIA TORREGO ARTOLA

Neumología

SOPHE GARCÍA FUIKA

Oncología

IRMA MURUZABAL ZALDIBAR

Oncología

IZASKUN FELIPE BLANCO

Oncología

AINHOA ULIBARRI OCHOA

Oncología

Producción científica

Avelumab maintenance in advanced urothelial carcinoma: real-world data from Northern Spain (AVEBLADDER study).
Sotelo, M, Pelaez, M, Basterretxea, L, Varga, E, Sánchez-Escribano, R, Obis, EP, Santander, C, Kareaga, MM, Ibarbia, MA, Ledesma, IR, Fernández, CA, Piedra, P, Aragón, VC, Lainez, N, Aguilar, JAV, Arnáiz, IG, Fernández, R, Mazas, C, Duran, I.

Clinical & Translational Oncology, 27, 4481-4492. 2025
DOI: 10.1007/s12094-025-03950-w
Real-World Data of First-Line Cemiplimab Monotherapy for Metastatic Non-Small Cell Lung Cancer (NSCLC) with PD-L1 Expression = 50%: A National Spanish Multicentric Cohort (CEMI-SPA Study).
Masini,S., Antoñanzas Basa,M., Calles,A., Cabellos,R.A., De Elejoste Echebarria,I., Traseira Puchol,C., Martinez Kareaga,M., Cabezon-Gutierrez,L., Escoin Perez,M.C., Lage,Y., Garcia Lorenzo,E., Navarro,F., Sereno,M., Falagán Martínez,S., García-Benito,C., Masfarre Pinto,L., Avila Andrade,C., Sequero,S., Mosquera Martinez,J., López-Martín,A., Azkárate Martínez,A., Martín-Soberón,M.C., Lucia-Gozalvez,C., Rubio,J., Tallafigo,L., Garrido,A., Peressini,M., Torres-Jimenez,J., Zurera,M., Bote,H., Ponce,S., Paz-Ares,L., Zugazagoitia,J., Baena,J..

Cancers, 17, 0-0. 2025
DOI: 10.3390/CANCERS17223643
Low rather than high interleukin-6 levels are associated with immune-related adverse events in cancer patients treated with immune checkpoint inhibitors.
Les, I, de Haedo, D, Martinez, M, Ibáñez-Beroiz, B, Moreno, A, de Elejoste, I, Campillo-Calatayud, A, Perez-Francisco, I, Cabero, M, Elejalde, I, Arrazubi, V.

Frontiers in Immunology, 16, 0-0. 2025
DOI: 10.3389/fimmu.2025.1677778
Observational study on the safety and effectiveness of SARS-CoV-2 vaccination in patients with lung cancer.
Nadal, E., Moran, T., Estival, A., Sala, M. A., Antonanzas, M., Gonzalez, J. G., Diz-Tain, M. P., Martinez, M., Azcona, E., Baena, J., Campos, B., Cumplido, J. D., Cerezo, S., Diaz-Serrano, A., Guirado, M., Mielgo, X., Saigi, M., Vidales, Z..

Esmo Real World Data And Digital Oncology, 8, 0-0. 2025
DOI: 10.1016/j.esmorw.2025.100125
KRAS Mutation Status in Non-Small Cell Lung Cancer: Distribution Across Occupational Categories..
Serna-Blasco, Roberto, Medina, Karla, Sala, Maria Angeles, Aguiar, David, Diaz-Serrano, Asuncion, Antonanzas, Monica, Gonzalez Larriba, Jose Luis, Ocana, Julio, Mielgo, Xabier, Fernandez, Inmaculada, Lopez-Castro, Rafael, Cobo, Manuel, Martinez, Mireia, Villa, Jose Carlos, Rosado, Petra, Lopez, Ana, Guirado, Maria, Viteri, Santiago, Rodriguez, Delvys, Garcia, Florencia, Simon, Soraya, Moreno, Maria Angeles, Catot, Silvia, Mediavilla, Pilar, Simon, Natalia Garcia, Octavio, Leonor, Calvo, Virginia, Romero, Atocha, Provencio, Mariano.

Chest, 0-0. 2025
DOI: 10.1016/j.chest.2025.06.043
Comprehensive molecular profiling of advanced NSCLC using NGS: Prevalence of druggable mutations and clinical trial opportunities in the ATLAS study..
Serna-Blasco, Roberto, Mediavilla-Medel, Pilar, Medina, Karla, Sala, Maria Angeles, Aguiar, David, Diaz-Serrano, Asuncion, Antonanzas, Monica, Ocana, Julio, Mielgo, Xabier, Fernandez, Inmaculada, Lopez-Castro, Rafael, Cobo, Manuel, Martinez, Mireia, Villa, Jose Carlos, Rosado, Petra, Lopez, Ana, Guirado, Maria, Viteri, Santiago, Rodriguez, Delvys, Garcia, Florencia, Simon, Soraya, Moreno, Maria Angeles, Catot, Silvia, Gonzalez Larriba, Jose Luis, Salas, Clara, Calvo, Virginia, Romero, Atocha, Provencio, Mariano.

LUNG CANCER, 204, 108550-108550. 2025
DOI: 10.1016/j.lungcan.2025.108550
1058P Transcriptomic insights into cisplatin resistance in testicular germ cell tumors: Molecular pathways and tumor microenvironment.
MARTINEZ KAREAGA, MIREIA.

Annals of Oncology, 0-0. 2025
DOI: 10.1016/j.annonc.2025.08.1697
1533P Immune-related adverse events and pre-existing autoimmune disease as prognostic biomarkers in patients treated with ICIs: Results from the AUTENTIC study (NCT05280055).
MARTINEZ KAREAGA, MIREIA.

Annals of Oncology, 0-0. 2025
DOI: 10.1016/j.annonc.2025.08.2164
1560P Role of interleukin-6 in immune-related adverse events occurrence: Analysis of a real-world, multicenter, prospective pan-cancer cohort.
MARTINEZ KAREAGA, MIREIA.

Annals of Oncology, 0-0. 2025
DOI: 10.1016/j.annonc.2025.08.2190
2371eP HUMA-LUNG project: Scalable implementation of a thoracic tumour functional unit (TTFU) to advance value-based care in a tertiary hospital.
MARTINEZ KAREAGA, MIREIA.

Annals of Oncology, 0-0. 2025
DOI: 10.1016/j.annonc.2025.08.2986